ARLINGTON, Va.--(BUSINESS WIRE)--The Medical Device Innovation Consortium (MDIC) today announced that its board of directors has elected Jijo James, Chief Medical Officer of Johnson & Johnson Medical Devices Companies, as the new chair-elect of the MDIC board.
James has been on the MDIC Board of Directors since 2017 and a member of the MDIC Executive Committee since 2018. He also chairs MDIC’s Clinical Science and Medical Officer forum, a group of senior scientific and medical executives from medical device and diagnostics companies, government, and non-profit organizations, that provides advice to MDIC’s Board on issues regarding clinical and regulatory science and patient safety to maximize clinical and medical value. As chair-elect of the board, James is next in line to become board chair in June 2021, succeeding current chair Nadim Yared, CEO of CVRx.
“Jijo has been a visionary advisor for MDIC and for me over the years. I look forward to further engaging his wisdom and vision for the next phase of MDIC, leveraging his knowledge as a physician and as a healthcare leader,” said MDIC President and CEO Pamela Goldberg.
As Chief Medical Officer for Johnson & Johnson Medical Devices Companies, James is responsible for overseeing patient monitoring and safety surveillance practices across the company’s Medical Devices product portfolio. James is a member of the Johnson & Johnson Office of the Chief Medical Officer Senior Leadership team and Medical Devices R&D Leadership team. Prior to joining Johnson & Johnson, James spent six years at Pfizer, Inc. where he held roles of increasing responsibility with safety and regulatory focuses both in the United States and abroad. He has extensive global experience working in emerging markets and with payers, providers and life sciences companies in a number of collaborative programs.
“This year has reminded us how critical medical device and diagnostic innovation is to the communities in which we live and work. I look forward to continuing the important work of MDIC in promoting patient access to innovative medical technologies while prioritizing safety and efficacy,” said James.
James began his medical career working directly with patients as a primary care physician in both urban and rural community settings. Having received his medical degree from St. John's Medical College in India, he later earned a Master of Public Health degree in Population and Family studies from the Joseph L. Mailman School of Public Health, Columbia University, New York, NY.
About the Medical Device Innovation Consortium
Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle. MDIC’s mission is to promote public health through science and technology and to enhance trust and confidence among stakeholders. MDIC works in the pre-competitive space to facilitate the development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Its initiatives aim to improve product safety and patient access to cutting-edge medical technology while reducing cost and time to market. For more information, visit http://www.mdic.org.
